convex

DRUG2 trials

Sponsors

Endeavor Biomedicines Inc., Odense University Hospital

Conditions

Kidney transplant recipientsidiopathic pulmonary fibrosis

Phase 2

A Phase 2, Multi-Center, Randomized, Double-Blind, Controlled Trial Evaluating the Safety and Efficacy of ENV-101 in Patients with Lung Fibrosis (WHISTLE-PF Trial)

RecruitingCTIS2024-511754-41-00

Endeavor Biomedicines Inc.idiopathic pulmonary fibrosis

Start: 2025-05-29Target: 140Updated: 2025-11-10

Phase 4

SGL-TX-GFR SGLT2i safety and efficacy on kidney allograft function in non-diabetic kidney transplant recipients: A randomized, double-blind, placebo controlled, national, multicenter trial.

RecruitingCTIS2024-518773-33-00

Odense University HospitalKidney transplant recipients

Start: 2025-08-12Target: 88Updated: 2025-06-20